Kowa na taɓa magana kan ƙara NAD+, amma sabon binciken dabbobi ya gano cewa wani enzyme mai suna CD38 na shafe NAD+. Maganin da ke hana CD38, CVN14, ya ƙara NAD+ a kwakwalwar beraye da linzami, kuma ya rage matsalolin motsi a samfurin cutar Parkinson. Amma wannan magani na gwaji ne daga kamfanin Cerevance, ba a sayar da shi a kasuwa ba, kuma an yi gwaje-gwajensa ne a dabbobi da ƙwayoyin sel, ba a mutane ba. Ga abin da wannan ke nufi ga masu siyan NMN da NR.
This page is available in